Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence

Prostate cancer is the second most frequent cancer worldwide, with a very high rate of progression despite treatment. The most aggressive form of the disease is known as castration-resistant prosta...